Thailand's Public Health Ministry is advancing plans to integrate medical cannabis into the country's health economy. This initiative aligns with recent changes in U.S. cannabis policy, as the U.S. eases restrictions on certain cannabis products. Public Health Minister Pattana Promphat announced these plans on April 27, highlighting a focus on medical cannabis as a vital economic driver.
Get today's headlines by email 
The U.S. has reclassified some marijuana products under federal law, moving them from Schedule I to Schedule III, which eases research, taxation, and financing barriers. This significant shift in U.S. policy impacts the global cannabis market, which is projected to surpass $47 billion by 2026, according to Reuters.
Thailand is preparing its legal framework to align with these global trends. The proposed framework encompasses the cultivation, sale, and use of cannabis, with guidelines already underway. The Ministry aims to advance these efforts post-Songkran, as part of a broader strategy to enhance Thailand's health economy through quality cannabis extracts.
Minister Pattana emphasized that Thailand will develop cannabis for strictly medical purposes, ensuring that the products meet international standards and avoid legal issues in export markets. While discussions are ongoing, concrete proposals will emerge soon.
The Bhumjaithai Party meeting did not address the Cannabis and Hemp Bill specifically, indicating that formal discussions are still being organized. Thailand is carefully considering international acceptance as it navigates the legislative process, ensuring that its cannabis-related policies are both economically and globally viable.
Join the discussion? 
Already a member? 
Adapted by ASEAN Now · The Nation · 27 Apr 2026